Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
Taranabant |
EINECS | N/A |
CAS No. | 701977-09-5 | Density | 1.3 g/cm3 |
PSA | 75.01000 | LogP | 6.70498 |
Solubility | N/A | Melting Point |
106.0-106.3 °C |
Formula | C27H25ClF3N3O2 | Boiling Point | 634.2 °C at 760 mmHg |
Molecular Weight | 515.963 | Flash Point | 337.4 °C |
Transport Information | N/A | Appearance | N/A |
Safety | Risk Codes | N/A | |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
MK 0364;N-[(1S,2S)-3-(4-Chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[(5-(trifluoromethyl)pyridin-2-yl)oxy]propanamide;N-[(1S,2S)-3-(4-Chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide;Taranabant; |
Article Data | 10 |
The IUPAC name of Taranabant is N-[(2S,3S)-4-(4-chlorophenyl)-3-(3-cyanophenyl)butan-2-yl]-2-methyl-2-[5-(trifluoromethyl)pyridin-2-yl]oxypropanamide. With the CAS registry number 701977-09-5, it is also named as N-[(1S,2S)-3-(4-Chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[(5-(trifluoromethyl)pyridin-2-yl)oxy]propanamide. The product's molecular formula is C27H25ClF3N3O2 and its molecular weight is 515.95. In addition, its classification code is treatment of obesity.
The other characteristics of the product can be summarized as:(1)ACD/LogP: 6.73 ; (2)# of Rule of 5 Violations: 2 ; (3)ACD/LogD (pH 5.5): 6.73 ; (4)ACD/LogD (pH 7.4): 6.73 ; (5)ACD/BCF (pH 5.5): 76508.2 ; (6) ACD/BCF (pH 7.4): 76508.88 ; (7)ACD/KOC (pH 5.5): 108977.62 ; (8)ACD/KOC (pH 7.4): 108978.57 ; (9)H bond acceptors: 5 ; (10)H bond donors: 1 ; (11)Freely Rotating Bonds: 8 ; (12)Index of Refraction: 1.575 ; (13)Molar Refractivity: 130.87 cm3 ; (14)Molar Volume: 395.9 cm3 ; (15)Surface Tension: 51.4 dyne/cm ; (16)Density: 1.3 g/cm3 ; (17)Flash Point: 337.4 °C ; (18)Enthalpy of Vaporization: 93.74 kJ/mol ; (19)Boiling Point: 634.2 °C at 760 mmHg ; (20)Vapour Pressure: 5.46E-16 mmHg at 25 °C.
Use of Taranabant: It is a cannabinoid receptor type 1 inverse agonist being investigated as a potential treatment for obesity due to its anorectic effects.
People can use the following data to convert to the molecule structure.
(1)SMILES:N#Cc1cccc(c1)[C@H](Cc2ccc(Cl)cc2)[C@@H](NC(=O)C(Oc3ncc(cc3)C(F)(F)F)(C)C)C;
(2)InChI:InChI=1/C27H25ClF3N3O2/c1-17(34-25(35)26(2,3)36-24-12-9-21(16-33-24)27(29,30)31)23(14-18-7-10-22(28)11-8-18)20-6-4-5-19(13-20)15-32/h4-13,16-17,23H,14H2,1-3H3,(H,34,35)/t17-,23+/m0/s1.